EP2552910 - Bibliographic data

NOUVEAU POLYMORPHE

Last update 08/06/2025
Legal status Brevet déchu
Origin Euro-PCT

(73) Holder

VANTIA LIMITED

Epsilon House Enterprise Road Southampton Science Park
Southampton SO16 7NS
Royaume-Uni
(72) Inventors

Johan KJELLSTRÖM

Ferring Pharmaceuticals A/S Late Stage Development Global Pharmaceutical R&D Kay Fiskers Plads 11
DK-2300 Copenhagen S
Danemark

Björn JOHANSON

Vimpelgatan 35
S-211 14 malmö
Suède

Thomas VILHELMSEN

Bygaden 8 Karlstrup
DK-2690 Karlslunde
Danemark
(74) Agent

Mail recipient

HALLYBONE, HUW GEORGE ET AL

Carpmaels & Ransford LLP One Southampton Row
London WC1B 5HA
Royaume-Uni

(21) Request number EP11714079.8
(22) Request date 31/03/2011

(11) Publication number EP2552910
Publication date 11/03/2015

(54) Title of the invention NOUVEAU POLYMORPHE
(51) International classification C07D 409/12A61K 31/53A61P 13/00A61P 13/02
International classification (before reform) None

Claimed priority

(31) Number: 347048 P
(32) Date: 21/05/2010
(33) Country: US

Initial application None
Divisional application None

Expected annuity Annuity: 5 - Amount: 55 € - Due date 11/05/2015
Surtax: 5 - Amount: 11 € - Due date 12/11/2015
Last annuity None

Publication

BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2015/23, of 05/06/2015

History

Publication de la délivrance du brevet européen - Legal date 11/03/2015


Entrée en période de grâce du brevet d'invention - Legal date 12/05/2015


Déchéance du brevet d'invention après période de grâce - Legal date 11/05/2015